Abingdon Health develops, manufactures and markets innovative medical diagnostics for clinics and laboratories worldwide to enable rapid, accurate, and low-cost diagnosis.
Our initial development focus is in the field of haematology oncology and specifically in the area of B-Cell dyscrasias. Our first rapid testing product in this market is Seralite® – FLC, the world’s first rapid device for aiding the diagnosis and monitoring of multiple myeloma patients.
Seralite® – FLC Serum
Rapid test for the quantitative measurement of free light chains (FLCs) in diagnosis and monitoring of multiple myeloma.Read More
Our distributors in the USA, Potadaho Seed Services, have launched their website. It looks great - click through an… https://t.co/Beb4XsEhgF
20 September 2018
© Abingdon Health 2018